• Organization Name 
    Apellis Pharmaceuticals
  • Announced Date Feb 12, 2016
  • Funding Type Series D
  • Funding Stage Late Stage Venture
  • Money Raised 
    $47M
  • Cormorant Asset Management Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles.
Number of Investors 6
Number of Partner Investors 1